Advertisement Axis-Shield signs new distribution agreements with Abbott and PSS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Axis-Shield signs new distribution agreements with Abbott and PSS

Axis-Shield, an in vitro diagnostics company, has renewed its Afinion US distribution contract with Abbott Laboratories and signed new agreements with Abbott's physician office laboratory partner PSS World Medical.

These agreements have an initial term to 2011 and effectively extend and strengthen existing distribution arrangements, giving Abbott and PSS exclusive marketing rights to the Afinion system in the US.

Ian Gilham, CEO of Axis-Shield, said: “These agreements reflect the commitment of Abbott and PSS to Afinion and its proven superiority for measuring HbA1c at the point of care. We look forward to increasing sales of our flagship Afinion system in the important US market.”